New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 6, 2014
04:55 EDTATHN, ATHN, JNJ, JNJ, CERN, CERN, UNH, UNH, SNY, SNY, PFE, PFE, MDT, MDT, CAH, CAH, BCR, BCR, AGTC, AGTCPiper Jaffray to hold a summit
3rd Annual Heartland Summit to be held in Minneapolis on August 6-7.
News For ATHN;BCR;CAH;MDT;PFE;SNY;UNH;CERN;JNJ;AGTC From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | all recent news | >>
September 23, 2014
08:55 EDTATHNathenahealth valuation 'still not tempting,' says FBR Capital
Subscribe for More Information
08:53 EDTMDTInversion regulations look more onerous than expected, says FBR Capital
FBR Capital says the new regulations announced last night by the Treasury and IRS contain appear more onerous than expected. FBR points out the proposed changes remove the ability of inverting companies to make "hopscotch loans" between the foreign and domestic subsidiaries. The firm believes the regulations will not end the practice of inversions, and it still expects completion of already announced deals.
08:07 EDTJNJ, UNHFDA Pediatric Advisory Committee to hold a meeting
Subscribe for More Information
07:05 EDTMDTMedtronic will still pursue Covidien deal, says Citigroup
Subscribe for More Information
06:40 EDTPFEPiper says don't dismiss potential Pfizer bid for Actavis
Piper Jaffray says it would not be dismissive of Pfizer (PFE) as a potential acquirer of Actavis (ACT). Piper believes Pfizer's public M&A comments are supportive of Actavis' exposure to complex generics and emerging markets. The firm views Actavis shares as attractively valued, irrespective of the acquisition chatter. It reiterates an Overweight rating on the stock with a $280 price target.
05:56 EDTMDTTreasury, IRS announce plans to reduce inversion tax benefits
Subscribe for More Information
September 22, 2014
15:44 EDTATHNathenahealth management to meet with JPMorgan
Subscribe for More Information
09:32 EDTMDTMedtronic announces CE Mark, European launch for TYRX envelope
Medtronic has received CE, or Conformité Européenne, Mark for the TYRX Absorbable Antibacterial Envelope, which covers an implantable cardiac device to help stabilize the device after implantation and reduce surgical-site infections.
09:10 EDTATHNathenahealth expands in Atlanta, San Francisco
athenahealth announced new office openings in Atlanta, Georgia, and San Francisco, California. As part of athenahealth's national growth strategy, the company is increasing its foothold in major health care and technology markets to meet the diverse needs of its growing client base.
07:50 EDTJNJDoctors continue to use morcellators despite FDA warning, J&J halt, WSJ says
Subscribe for More Information
07:21 EDTSNYEBD Group to hold a conference
Subscribe for More Information
07:07 EDTJNJSynageva appoints Robert Bazemore as COO
Synageva announced the appointment of Robert Bazemore as Chief Operating Officer. Bazemore will oversee the planned global commercial launch of the company's lead program, sebelipase alfa for LAL Deficiency, and will have responsibility for the company's global commercial, market access and medical affairs operations. Bazemore last served at Johnson & Johnson (JNJ) in varoius roles including Vice President, Ethicon New Growth Platforms and President of Janssen Biotech, a part of the Janssen Pharmaceutical Companies of Johnson & Johnson.
September 19, 2014
16:00 EDTPFEOptions Update; September 19, 2014
Subscribe for More Information
11:35 EDTCERN, ATHNCerner, Athenahealth developing applications for Apple HealthKit, Reuters says
Cerner (CERN) and Athenahealth (ATHN) said yesterday that they are working with Apple (AAPL) to develop applications for Apple's HealthKit, Reuters reports, citing Cerner and Athenahealth representatives. Athena said they will be utilizing HealthKit to assist patients with chronic conditions like diabetes, while Cerner said that doctors and nurses will be able to access health data from the patients HealthKit with consent, Reuters added. Reference Link
11:25 EDTMDTSenators bring bill requiring companies to settle before inverting
U.S. Senators Sherrod Brown and Dick Durbin announced new legislation requiring corporations to "Pay What You Owe Before You Go" – settling their U.S. tax bill before relocating to a foreign country. "Everyone knows that before you leave a restaurant you have to settle your tab," Brown said. "Corporations shouldn’t get to play by different rules. While it is critical that we reach a long-term solution that reforms our international corporate tax code by implementing a global minimum tax and reducing the statutory tax rate, this bill is an immediate, commonsense measure to ensure businesses settle up before leaving the U.S." Among the deals or possible transactions that involve inversion are Mylan's (MYL) acquisition of Abbott (ABT), Medtronic's (MDT) acquisition of Covidien (COV) and Valeant's (VRX) proposed takeover of Allergan (AGN).
10:07 EDTPFEHigh option volume stocks
Subscribe for More Information
06:49 EDTUNHGovernment says 7.3M in private Obamacare plans, NY Times reports
Subscribe for More Information
06:19 EDTBCRC.R. Bard management to meet with JMP Securities
Meeting to be held in Boston on September 23 hosted by JMP Securities.
September 18, 2014
18:46 EDTCERNCerner receives regulatory clearance for acquisition of Siemens Health Services
Cerner (CERN) announced the U.S. Federal Trade Commission granted early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, in connection with the company's purchase of the assets of Siemens' (SIEGY) health information technology business unit, Siemens Health Services, for $1.3B in cash. The early termination of the HSR waiting period satisfies one of the conditions to the closing of the pending acquisition. The transaction remains subject to other customary closing conditions and is still expected to close in the first quarter of 2015.
12:18 EDTMDTNY AG announces national settlement with Medtronic for Medicaid violations
Attorney General Eric T. Schneiderman announced that 46 states and the District of Columbia have reach a settlement agreement with Minnesota-based company Medtronic to resolve claims under the False Claims Act that Medtronic improperly induced physicians to recommend Medtronic devices to treat cardiac rhythmic disease. New York led a national team composed of members from Oregon, Texas and California to negotiate the settlement. The federal government settled its matter in May of this year...The agreement requires Medtronic to pay the settling states $362,362, which will go to those states’ Medicaid programs. The matter was brought by a whistleblower, Adolfo Schroeder, and was filed in U.S. District Court for the Eastern District of California. The Attorney General would like to thank Mr. Schroeder for bringing this matter to the government’s attention. Under the terms of the agreement, the New York Medicaid Program will receive $67,369.31. Reference Link
1 | 2 | 3 | 4 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use